Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 2
1971 1
1973 1
1976 1
1985 1
1986 1
1990 1
1995 1
1997 1
2001 1
2003 2
2004 2
2005 4
2006 7
2007 9
2008 14
2009 8
2010 2
2011 22
2012 26
2013 21
2014 25
2015 22
2016 15
2017 17
2018 15
2019 29
2020 28
2021 29
2022 24
2023 30
2024 35
2025 38

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

385 results

Results by year

Filters applied: . Clear all
Page 1
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, Montgomery J, Nizam A, Lane BF, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Lynch JR, Zaidat OO, Rumboldt Z, Cloft HJ; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators. Derdeyn CP, et al. Lancet. 2014 Jan 25;383(9914):333-41. doi: 10.1016/S0140-6736(13)62038-3. Epub 2013 Oct 26. Lancet. 2014. PMID: 24168957 Free PMC article. Clinical Trial.
Stenting versus aggressive medical therapy for intracranial arterial stenosis.
Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, Janis LS, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Torbey MT, Zaidat OO, Rumboldt Z, Cloft HJ; SAMMPRIS Trial Investigators. Chimowitz MI, et al. N Engl J Med. 2011 Sep 15;365(11):993-1003. doi: 10.1056/NEJMoa1105335. Epub 2011 Sep 7. N Engl J Med. 2011. PMID: 21899409 Free PMC article. Clinical Trial.
Single cell and TCR analysis of immune cells from AAV gene therapy-dosed Duchenne muscular dystrophy patients.
Emami MR, Brimble MA, Espinoza A, Owens J, Whiteley LO, Casinghino S, Lanz TA, Farahat PK, Pellegrini M, Young CS, Thomas PG, McNally EM, Villalta SA, Schattgen SA, Spencer MJ. Emami MR, et al. Mol Ther Methods Clin Dev. 2024 Sep 30;32(4):101349. doi: 10.1016/j.omtm.2024.101349. eCollection 2024 Dec 12. Mol Ther Methods Clin Dev. 2024. PMID: 39524974 Free PMC article.
Commentary.
Emami M. Emami M. J Neurosci Rural Pract. 2015 Jul-Sep;6(3):452. J Neurosci Rural Pract. 2015. PMID: 26167045 Free PMC article. No abstract available.
Rescue effect of curcumin against copper toxicity.
Maghool F, Emami MH, Alipour R, Mohammadzadeh S, Sereshki N, Dehkordi SAE, Fahim A, Tayarani-Najaran Z, Sheikh A, Kesharwani P, Sahebkar A. Maghool F, et al. Among authors: emami mh. J Trace Elem Med Biol. 2023 Jul;78:127153. doi: 10.1016/j.jtemb.2023.127153. Epub 2023 Mar 14. J Trace Elem Med Biol. 2023. PMID: 36989586 Review.
385 results